×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Glaxosmithkline Pharma
Glaxosmithkline Pharma
Neutral GlaxoSmithKline Pharma; target of Rs 1300: Motilal Oswal
Buy Britannia, GSK Pharma; sell HDIL, SAIL: Parag Doctor
Bull's Eye: Buy Britannia, Videocon; short HDIL, RComm
Angel Broking neutral on GlaxoSmithKline Pharma
Accumulate GSK Pharma; target of Rs 2104: Dolat Capital
How to trade pharma stocks ahead of Q4 earnings
Buy GSK Pharma; target of Rs 2234: Motilal Oswal
Sell GlaxoSmithKline Pharma; tgt of Rs 1880: PINC Research
GlaxoSmithKline Pharma Q4 net up 18% at Rs 136.74 cr
Buy JSW Steel, GlaxoSmithKline Pharma, says Sukhani
Angel Broking neutral on GlaxoSmithKline Pharma
Angel Broking neutral on GlaxoSmithKline Pharma
Sell GSK Pharma; target of Rs 1809: PINC Research
Angel Broking neutral on GlaxoSmithKline Pharma
Hold GlaxoSmithKline Pharma; target of Rs 2161: Emkay
Angel Broking neutral on GlaxoSmithKline Pharma
Sell GSK Pharma; target of Rs 1754: PINC Research
GSK Pharma Dec qtr PAT seen up 11% at Rs 114.9cr: Karvy
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio